Reply to: Comments on “Systemic exposure of oxaliplatin and docetaxel in gastric patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy”

W. J. Koemans, J. W. van Sandick*, A. D.R. Huitema

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Pages (from-to)2343-2343
Number of pages1
JournalEuropean Journal of Surgical Oncology
Volume46
Issue number12
DOIs
Publication statusPublished - Dec 2020

Keywords

  • Docetaxel
  • Humans
  • Hyperthermic Intraperitoneal Chemotherapy
  • Oxaliplatin/therapeutic use
  • Peritoneal Neoplasms/drug therapy
  • Peritonitis/chemically induced
  • Stomach Neoplasms/drug therapy

Cite this